These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20032229)

  • 21. Influence of IL6R rs8192284 polymorphism status in disease activity in rheumatoid arthritis.
    Lamas JR; Rodríguez-Rodríguez L; Varadé J; López-Romero P; Tornero-Esteban P; Abasolo L; Urcelay E; Fernández-Gutiérrez B
    J Rheumatol; 2010 Aug; 37(8):1579-81. PubMed ID: 20551110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?
    Gao IK; Haas-Wöhrle A; Mueller KG; Lorenz HM; Fiehn C
    Ann Rheum Dis; 2005 Oct; 64(10):1516-7. PubMed ID: 16162906
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
    Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
    Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
    Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss-of-function mutations in the filaggrin gene: no contribution to disease susceptibility, but to autoantibody formation against citrullinated peptides in early rheumatoid arthritis.
    Hüffmeier U; Böiers U; Lascorz J; Reis A; Burkhardt H
    Ann Rheum Dis; 2008 Jan; 67(1):131-3. PubMed ID: 17704064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.
    Cantaert T; Coucke P; De Rycke L; Veys EM; De Keyser F; Baeten D
    Ann Rheum Dis; 2005 Sep; 64(9):1316-20. PubMed ID: 15760928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
    Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
    Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis.
    Bugatti S; Caporali R; Manzo A; Sakellariou G; Rossi S; Montecucco C
    Ann Rheum Dis; 2012 Apr; 71(4):625-6. PubMed ID: 22039169
    [No Abstract]   [Full Text] [Related]  

  • 38. [Autoantibodies as predictors of biological therapy for early rheumatoid arthritis].
    da Mota LM; dos Santos Neto LL; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Acta Reumatol Port; 2010; 35(2):156-66. PubMed ID: 20711091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effect of foot disease activity on Boolean remission in Japanese patients with rheumatoid arthritis: A cross-sectional study.
    Tokunaga K; Shiraishi A; Hagino N; Oshikawa H; Nishino J; Tohma S
    Musculoskeletal Care; 2019 Mar; 17(1):152-155. PubMed ID: 30421511
    [No Abstract]   [Full Text] [Related]  

  • 40. The intrafamilial transmission of rheumatoid arthritis. II. An interview measure of rheumatoid arthritis.
    Cobb S; Hunt P; Harburg E
    J Chronic Dis; 1969 Sep; 22(4):203-15. PubMed ID: 5822878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.